trial

RCT of tDCS Combined With Cognitive Training in Schizophrenia

NCTId NCT04870996
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 44 (actual)
Sponsored by CHAN SAU MAN, SANDRA
Primary completion 2020-06-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
44 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2019-08-23
Primary completion
2020-06-30
Eligibility
FEMALE · 18 Years · 65 Years

Interventions & indications

Drugs
TDCSCognitive training

Sponsors

CHAN SAU MAN, SANDRALead Sponsor

Investigators

1
Ka Ying Heidi Lo, MBChBPrincipal Investigator

Sites

1 total
Hong Kong, Hong Kong

Facts & assertions

4 sourced
Enrollment
44
Phase
NA
Primary Completion Date
2020-06-30
Status
COMPLETED
relationships
The graph out of here
drug
TDCS
drug
Cognitive training
drug
lead_sponsor
CHAN SAU MAN, SANDRA
company
indication
Schizophrenia
indication
Schizophrenia
indication
Cognitive Dysfunction
indication
investigator
Ka Ying Heidi Lo, MBChB
person